Alpha Arbutin vs Hydroquinone
Which is right for your skin?
Hydroquinone is stronger and faster but meant for short, supervised courses; alpha arbutin is the gentle everyday alternative you can use long-term. Start with arbutin unless a dermatologist prescribed hydroquinone.
A safer, slower-acting alternative to prescription-strength dark-spot faders. Built for long-term use without irritation.
The gold-standard fade ingredient for dark spots and melasma. Prescription-only and meant for short-term use under a dermatologist.
Can you use Alpha Arbutin and Hydroquinone together?
Yes — Alpha Arbutin and Hydroquinone are documented to pair well together.
You want brightening. A safer, slower-acting alternative to prescription-strength dark-spot faders. Built for long-term use without irritation.
You want brightening. The gold-standard fade ingredient for dark spots and melasma. Prescription-only and meant for short-term use under a dermatologist. (Prescription only.)
Cited research
Marziya M et al., Mechanism of Cyanotis arachnoidea Gel in improving melasma based on network pharmacology and transcriptomics, Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica) 2025;50(13):3775-3790 — Southwest Minzu University Chengdu; arbutin gel as positive-control comparator in melasma rat model
Sarkar R et al., Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and alpha-Arbutin in Indian Females With Facial Melasma, Journal of Cosmetic Dermatology 2025;24(2):e16753 — 120 Indian women: 10% THBG + 2% alpha-arbutin reduced melanin 16.3% and mMASI 18.4% with good tolerability
Ma ZY, Lu Y, Melanin synthesis and regulation in vivo and commonly used melanin inhibitors from natural products and traditional Chinese medicine, Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica) 2020;45(24):5898-5916 — Beijing University of Chinese Medicine review classifies arbutin among tyrosinase-active-site-targeting melanin inhibitors
MFDS Approved Functional Cosmetic Active — Alpha-Arbutin (whitening). Korean Ministry of Food and Drug Safety, Cosmetic Functional Active Ingredient List; authorized concentration documented in Jeon JS et al., Simultaneous determination of water-soluble whitening ingredients and adenosine in different cosmetic formulations, International Journal of Cosmetic Science 2016;38(3):286-93 (PMID:26564311) per the Korean Cosmetic Act and Functional Cosmetics Codex
Morag M et al., A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations, Journal of Cosmetic Dermatology 2015 — 76% of melasma patients showed clinical lightening over 8 weeks
Dreher F et al., Efficacy of hydroquinone-free skin-lightening cream for photoaging, Journal of Cosmetic Dermatology 2013 — arbutin-containing hydroquinone-free formulation reduced mottled hyperpigmentation 32% at 12 weeks
Kim H, Choi HR, Kim DS, Park KC, Topical hypopigmenting agents for pigmentary disorders and their mechanisms of action, Annals of Dermatology 2012;24(1):1-6 — review classifies arbutin among hypopigmenting agents via tyrosinase regulation as a hydroquinone alternative
Seo DH et al., Biotechnological production of arbutins (alpha- and beta-arbutins), skin-lightening agents, and their derivatives, Applied Microbiology and Biotechnology 2012;95(6):1417-1425 — review documenting arbutin glycosylated hydroquinones as competitive tyrosinase inhibitors producing skin-whitening effect with improved safety vs hydroquinone
Ertam I et al., Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study, Journal of Dermatology 2008 — arbutin (and ellagic acid) formulations effectively reduced melasma severity
Lima PB et al., Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded RCT, JEADV 2021;35(9):1881-1887 — 4% hydroquinone produced melasma improvement equivalent to Thiamidol
McKesey J et al., Melasma Treatment: An Evidence-Based Review, American Journal of Clinical Dermatology 2020;21(2):173-225 — topical hydroquinone and triple combination remain superior first-line options for melasma
Petit A, Skin lightening and its motives: A historical overview, Annales de Dermatologie et de Venereologie 2019;146(5):399-409 — Hopital Saint-Louis AP-HP Paris historical review of skin-lightening practices including HQ use, safety profile, cultural drivers of cosmetic misuse
Kim GH, Cheong KA, Lee AY, Increased Skin Irritation by Hydroquinone and Retinoic Acid Used in Combination, Annals of Dermatology 2017;29(6):715-721 — HQ + retinoic acid combination significantly increases skin irritation vs either alone, in patch testing and keratinocyte assays
CIR Amended Safety Assessment of Hydroquinone as Used in Cosmetics, final amended report December 2014
Guerrero D, [Dermocosmetic management of hyperpigmentations], Annales de Dermatologie et de Venereologie 2012;139 Suppl 3:S115-S118 — French derm review of depigmenting strategies; HQ remains the Kligman-formula benchmark prescription agent but is restricted; dermocosmetic alternatives reviewed
Rajaratnam R et al., Interventions for melasma, Cochrane Database of Systematic Reviews 2010;7:CD003583 — triple combination, azelaic acid, and tretinoin showed efficacy; overall "available treatments inadequate"
Nordlund JJ et al., The safety of hydroquinone, Journal of the European Academy of Dermatology and Venereology 2006;20(7):781-7 — concluded strong safety record after 40-50 years of medical use
Guevara IL, Pandya AG, Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma, International Journal of Dermatology 2003;42(12):966-972 — 4% HQ + glycolic + antioxidants was safe and effective for melasma
Every entry points to a specific paper or regulatory document. See methodology for what each outcome label means.